# TNBI (Tanke Biosciences Corp.) - SEC EDGAR Financial Statements

> Tanke Biosciences Corp. reported $22.96M in revenue and a net loss of $1.64M for the trailing twelve months ended September 30, 2013 (down 39.0% year over year), with a 32.3% gross margin and a -0.2% operating margin.

- Canonical: https://convexityos.com/fundamentals/TNBI
- Markdown: https://convexityos.com/fundamentals/TNBI.md
- SEC CIK: 0001452011
- Reporting currency: USD
- Latest filing period: September 30, 2013
- Last synced: Nov 21, 2026, 05:14 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001452011&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $22.96M | -39.0% YoY |
| Operating Income | TTM | -$57K | -0.2% margin |
| Net Income | TTM | -$1.64M | -7.1% net margin |
| Diluted EPS | TTM | -$0.12 | Split-adjusted |
| Free Cash Flow | TTM | -$6.13M | -26.7% FCF margin |
| Cash & ST Investments | Sep 30, 2013 | $5.05M | Total debt: $1.87M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
| --- | --- | --- | --- | --- |
| **Revenue** | $28.56M | $23.83M | $20.10M | -- |
| Cost of Revenue | $18.62M | $15.06M | $12.70M | -- |
| **Gross Profit** | $9.94M | $8.77M | $7.40M | -- |
| Research & Development | $291K | $246K | -- | -- |
| Selling, General & Admin | $5.25M | $6.95M | $2.72M | -- |
| **Operating Income** | $4.53M | $1.74M | $4.37M | -- |
| **EBITDA** | $5.17M | $2.14M | $4.51M | -- |
| Interest Income | $296K | $96K | $4.8K | -- |
| Interest Expense | $1.45M | $1.36M | $100K | -- |
| Income Before Tax | $603K | -$2.45M | $4.28M | -- |
| Income Tax Expense | $832K | $681K | $582K | -- |
| **Net Income** | -$210K | -$3.14M | $2.74M | $2.58M |
| Basic EPS | -$0.02 | -$0.24 | $0.34 | -- |
| **Diluted EPS** | -$0.02 | -$0.24 | $0.34 | -- |
| Basic Shares Outstanding | 13.3M | 13.1M | 10.8M | -- |
| Diluted Shares Outstanding | 13.3M | 13.1M | 10.8M | -- |

### Income Statement (Quarterly)

| Line Item | Sep 2013 | Jun 2013 | Mar 2013 | Dec 2012 | Sep 2012 | Jun 2012 | Mar 2012 | Dec 2011 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $6.04M | $5.58M | $4.66M | $6.68M | $9.91M | $7.43M | $4.54M | $6.65M |
| Cost of Revenue | $4.35M | $3.75M | $2.99M | $4.45M | $6.52M | $4.69M | $2.95M | $4.33M |
| **Gross Profit** | $1.69M | $1.82M | $1.67M | $2.23M | $3.39M | $2.74M | $1.59M | $2.33M |
| Selling, General & Admin | $2.15M | $1.62M | $1.64M | $1.75M | $1.19M | $1.23M | $1.09M | $1.39M |
| **Operating Income** | -$530K | $150K | -$40K | $363K | $2.18M | $1.50M | $489K | $1.02M |
| **EBITDA** | -$287K | $356K | $140K | $595K | $2.34M | $1.62M | $612K | $1.29M |
| Interest Income | $147K | $19K | $7.3K | $103K | $24K | $148K | $21K | $67K |
| Interest Expense | -$47K | $39K | $215K | $387K | $316K | $369K | $373K | -$136K |
| Income Before Tax | -$340K | $169K | -$647K | -$620K | $1.19M | $586K | -$554K | $2.16M |
| Income Tax Expense | -$27K | $54K | $32K | $179K | $223K | $314K | $117K | $176K |
| **Net Income** | -$302K | $118K | -$676K | -$780K | $969K | $272K | -$671K | $1.99M |
| Basic EPS | -$0.02 | $0.01 | -$0.05 | -- | $0.07 | $0.02 | -$0.05 | -- |
| **Diluted EPS** | -$0.02 | $0.01 | -$0.05 | -- | $0.07 | $0.02 | -$0.05 | -- |
| Basic Shares Outstanding | 13.3M | 13.3M | 13.3M | -- | 13.3M | 13.3M | 13.3M | -- |
| Diluted Shares Outstanding | 13.3M | 13.3M | 13.3M | -- | 13.3M | 13.3M | 13.3M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2012 | FY 2011 | FY 2010 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $6.17M | $7.70M | $2.22M |
| **Cash & Short-Term Investments** | $6.17M | $7.70M | $2.22M |
| Accounts Receivable, Net | $1.99M | $1.92M | $1.77M |
| Inventory | $1.41M | $1.19M | $1.35M |
| Other Current Assets | $133K | $915K | $165K |
| **Total Current Assets** | $22.37M | $18.91M | $7.67M |
| Property, Plant & Equipment, Net | $4.81M | $4.77M | $1.55M |
| Intangible Assets | $1.24M | $838K | $287K |
| Other Non-Current Assets | $135K | $328K | $0 |
| **Total Non-Current Assets** | $6.48M | $5.97M | $5.59M |
| **Total Assets** | $28.85M | $24.89M | $13.27M |
| Accounts Payable | $647K | $785K | $605K |
| Short-Term Debt | $1.27M | $785K | $906K |
| **Total Current Liabilities** | $12.10M | $3.55M | $2.41M |
| Long-Term Debt | $793K | $628K | $453K |
| **Total Non-Current Liabilities** | $831K | $5.49M | $526K |
| **Total Liabilities** | $12.93M | $9.03M | $2.93M |
| **Total Debt (incl. Leases)** | $2.06M | $1.41M | $1.36M |
| Common Stock | $13K | $13K | $11K |
| Retained Earnings | $2.49M | $2.70M | $5.83M |
| Accumulated Other Comp. Income | $659K | $551K | $530K |
| **Total Stockholders' Equity** | $15.75M | $15.85M | $8.16M |
| Total Equity | $15.92M | $15.85M | $10.33M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2013 | Jun 2013 | Mar 2013 | Dec 2012 | Sep 2012 | Mar 2012 | Dec 2011 | Sep 2011 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $5.05M | $4.72M | $5.59M | $6.17M | $11.04M | $7.64M | $7.70M | $10.22M |
| **Cash & Short-Term Investments** | $5.05M | $4.72M | $5.59M | $6.17M | $11.04M | $7.64M | $7.70M | $10.22M |
| Accounts Receivable, Net | $2.76M | $2.38M | $1.85M | $1.99M | $2.28M | $1.72M | $1.92M | $5.06M |
| Inventory | $1.65M | $2.08M | $1.40M | $1.41M | $1.64M | $1.36M | $1.19M | $1.08M |
| Other Current Assets | $30K | $8.2K | $18K | $133K | $340K | $746K | $915K | $1.42M |
| **Total Current Assets** | $19.70M | $21.92M | $21.74M | $22.37M | $22.20M | $18.37M | $18.91M | $21.24M |
| Property, Plant & Equipment, Net | $6.34M | $5.26M | $5.16M | $4.81M | $4.92M | $4.88M | $4.77M | $4.58M |
| Intangible Assets | $1.15M | $1.19M | $1.20M | $1.24M | $1.27M | $845K | $838K | $301K |
| Other Non-Current Assets | -- | -- | -- | $135K | $121K | $359K | $328K | -- |
| **Total Non-Current Assets** | $9.11M | $7.55M | $6.92M | $6.48M | $6.64M | $6.08M | $5.97M | $5.18M |
| **Total Assets** | $28.81M | $29.47M | $28.66M | $28.85M | $28.84M | $24.45M | $24.89M | $26.41M |
| Accounts Payable | $641K | $843K | $659K | $647K | $582K | $514K | $785K | $551K |
| Short-Term Debt | $1.14M | $1.29M | $797K | $1.27M | $1.34M | $1.11M | $785K | $708K |
| **Total Current Liabilities** | $12.24M | $12.70M | $11.79M | $12.10M | $11.16M | $8.82M | $3.55M | $5.18M |
| Long-Term Debt | $733K | $809K | $1.43M | $793K | $948K | $0 | $628K | $944K |
| **Total Non-Current Liabilities** | $863K | $891K | $1.48M | $831K | $1.15M | $335K | $5.49M | $6.87M |
| **Total Liabilities** | $13.10M | $13.59M | $13.28M | $12.93M | $12.31M | $9.16M | $9.03M | $12.05M |
| **Total Debt (incl. Leases)** | $1.87M | $2.10M | $2.23M | $2.06M | $2.29M | $1.11M | $1.41M | $1.65M |
| Common Stock | $13K | $13K | $13K | $13K | $13K | $13K | $13K | $13K |
| Retained Earnings | $1.63M | $1.93M | $1.81M | $2.49M | $3.27M | $2.03M | $2.70M | $1.08M |
| Accumulated Other Comp. Income | $1.32M | $1.17M | $791K | $659K | $660K | $664K | $551K | $1.04M |
| **Total Stockholders' Equity** | $15.56M | $15.71M | $15.21M | $15.75M | $16.53M | $15.30M | $15.85M | -- |
| Total Equity | $15.71M | $15.88M | $15.38M | $15.92M | $16.53M | $15.30M | $15.85M | $14.36M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
| --- | --- | --- | --- | --- |
| Net Income | -$229K | -$3.14M | $3.69M | $2.58M |
| Depreciation & Amortization | $636K | $400K | $136K | -- |
| Stock-Based Compensation | -- | $2.49M | $0 | -- |
| Change in Receivables | -$172K | -$170K | -$240K | -- |
| Change in Inventory | -$227K | $173K | -$334K | -- |
| Change in Payables | -$138K | $153K | $555K | -- |
| **Operating Cash Flow** | -$1.18M | $3.65M | $4.38M | -- |
| Capital Expenditure | -$856K | -$701K | -$76K | -- |
| **Free Cash Flow** | -$2.04M | $2.95M | $4.31M | -- |
| **Investing Cash Flow** | -$1.53M | -$3.67M | -$2.82M | -- |
| **Financing Cash Flow** | $1.12M | $5.82M | -$1.22M | -- |
| **Net Change in Cash** | -$1.53M | $5.48M | $404K | -- |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2013 | Jun 2013 | Mar 2013 | Dec 2012 | Sep 2012 | Jun 2012 | Mar 2012 | Dec 2011 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$313K | $116K | -$679K | -$799K | $969K | $272K | -$671K | $1.99M |
| Depreciation & Amortization | $243K | $206K | $180K | $232K | $160K | $121K | $124K | $274K |
| Stock-Based Compensation | -- | -- | -- | -- | -- | -- | $0 | -- |
| Change in Receivables | -$214K | -$493K | $139K | $186K | -$460K | -$94K | $197K | $2.98M |
| Change in Inventory | $349K | -$602K | $17K | $223K | -$381K | $103K | -$172K | -$156K |
| Change in Payables | -$202K | $184K | $13K | $65K | -$102 | $68K | -$271K | $232K |
| **Operating Cash Flow** | $1.61M | -$135K | -$101K | -$5.01M | $1.55M | $1.77M | $509K | $731K |
| Capital Expenditure | -$1.07M | -$613K | -$746K | -$56K | -$412K | -$195K | -$194K | -$224K |
| **Free Cash Flow** | $538K | -$748K | -$847K | -$5.07M | $1.14M | $1.57M | $315K | $507K |
| **Investing Cash Flow** | -$1.08M | -$645K | -$746K | $114K | -$394K | -$866K | -$380K | -$2.11M |
| **Financing Cash Flow** | -$241K | -$159K | $230K | $76K | -$45K | $1.40M | -$305K | -$466K |
| **Net Change in Cash** | $329K | -$861K | -$583K | -$4.87M | $1.01M | $2.40M | -$64K | -$2.52M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
| --- | --- | --- | --- | --- |
| **Gross Margin** | 34.8% | 36.8% | 36.8% | -- |
| **Operating Margin** | 15.9% | 7.3% | 21.8% | -- |
| **Net Profit Margin** | -0.7% | -13.2% | 13.6% | -- |
| Return on Equity (ROE) | -1.3% | -19.8% | 33.5% | -- |
| Return on Assets (ROA) | -0.7% | -12.6% | 20.6% | -- |
| Current Ratio | 1.85x | 5.33x | 3.19x | -- |
| Quick Ratio | 1.73x | 5.00x | 2.63x | -- |
| Debt to Equity | 0.13x | 0.09x | 0.17x | -- |
| **Revenue Growth (YoY)** | +19.8% | +18.6% | -- | -- |
| Gross Profit Growth (YoY) | +13.4% | +18.5% | -- | -- |
| Operating Income Growth (YoY) | +160.6% | -60.2% | -- | -- |
| **Net Income Growth (YoY)** | -- | -214.5% | +6.0% | -- |
| EPS Growth (YoY) | -- | -170.6% | -- | -- |
| Operating Cash Flow Growth (YoY) | -132.4% | -16.7% | -- | -- |
| Free Cash Flow Growth (YoY) | -169.1% | -31.5% | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2013 | Jun 2013 | Mar 2013 | Dec 2012 | Sep 2012 | Jun 2012 | Mar 2012 | Dec 2011 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 32.3% | 33.9% | 34.9% | 34.8% | 35.2% | 35.8% | -- | -- |
| **Operating Margin** | -0.2% | 9.9% | 14.0% | 15.9% | 18.2% | 16.9% | -- | -- |
| **Net Profit Margin** | -7.1% | -1.4% | -0.8% | -0.7% | 9.0% | 0.6% | -- | -- |
| Return on Equity (ROE) | -10.5% | -2.4% | -1.4% | -1.3% | 15.5% | -- | -- | -- |
| Return on Assets (ROA) | -5.7% | -1.3% | -0.8% | -0.7% | 8.9% | -- | -- | -- |
| Current Ratio | 1.61x | 1.73x | 1.84x | 1.85x | 1.99x | -- | 2.08x | 5.33x |
| Quick Ratio | 1.48x | 1.56x | 1.72x | 1.73x | 1.84x | -- | 1.93x | 5.00x |
| Debt to Equity | 0.12x | 0.13x | 0.15x | 0.13x | 0.14x | -- | 0.07x | 0.09x |
| **Revenue Growth (YoY)** | -39.0% | -25.0% | +2.6% | +0.4% | +58.6% | -- | -23.6% | -- |
| Gross Profit Growth (YoY) | -50.0% | -33.5% | +4.9% | -4.1% | +50.9% | -- | -34.6% | -- |
| Operating Income Growth (YoY) | -124.3% | -90.0% | -108.2% | -64.4% | +81.3% | -- | -- | -- |
| **Net Income Growth (YoY)** | -131.2% | -56.6% | -- | -139.2% | -- | -- | -- | -- |
| EPS Growth (YoY) | -128.6% | -50.0% | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | +3.8% | -107.6% | -119.9% | -785.6% | -- | -- | -53.9% | -- |
| Free Cash Flow Growth (YoY) | -52.8% | -147.6% | -368.9% | -1100.2% | -- | -- | -64.7% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
